Rectovaginal fistula in a cervical cancer patient treated with sequential radiotherapy and bevacizumab: A dose‐volume analysis

Rectovaginal fistula in a cervical cancer patient treated with sequential radiotherapy and bevacizumab: A dose‐volume analysis

Abstract Bevacizumab is a monoclonal antibody against vascular endothelial growth factor that exerts antitumor effect by preventing tumor angiogenesis. Gastrointestinal fistula is a common side effect of bevacizumab in combination with radiotherapy. This case of rectovaginal fistula indicates that t...

Full description

Bibliographic Details
Main Authors: Kento Tomizawa, Ken Ando, Hirofumi Shimada, Takuya Kaminuma, Kazutoshi Murata, Takahiro Oike, Tatsuya Ohno
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Clinical Case Reports
Subjects:
bevacizumab
cervical cancer
dose‐volume analysis
radiation
rectovaginal fistula
Online Access:https://doi.org/10.1002/ccr3.3955

Similar Items

Similar Items